West Pharmaceutical Services
As on 02 Jul, 2025 | 01:29 IST
| Open | 218.59 |
| Previous Close | 218.80 |
| Beta | 0.41 |
| High | 226.80 |
| Low | 216.96 |
| TTM EPS See historical trend | 6.64(-13.32% YoY) |
| 52 Week High | 351.17 |
| 52 Week Low | 187.46 |
| TTM PE See historical trend | 33.49(Low PE) |
| Mkt. Cap ($ Billion) | 16.28 |
| Dividend Yield | 0.38 |
Advanced Chart
*Delayed by 20 seconds.
MC Technicals
| Days | |
|---|---|
| 5 | 220.23 |
| 10 | 219.36 |
| 20 | 220.24 |
| 50 | 215.11 |
| 100 | 226.18 |
| 200 | 271.6 |
Returns
| 1 Week | -2.99% | |
| 1 Month | 1.90% | |
| 3 Months | 10.20% | |
| YTD | -32.09% | |
| 1 Year | -32.07% | |
| 3 Years | -25.99% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| J&J | 178.38 | -0.21 | 429.88 | 17.84 | 10.00 | 2.99 | 181.14/141.30 | 6.17 | Very Bullish |
| Medtronic | 92.93 | 0.14 | 112.28 | 16.80 | 5.53 | 3.02 | 96.17/79.31 | 0.45 | Bullish |
| Becton, Dickinson and Co. | 192.16 | 0.47 | 55.78 | 13.48 | 14.27 | 2.36 | 251.38/163.46 | 5.44 | Bearish |
| West Pharmaceutical Services | 250.73 | 1.29 | 16.28 | 33.49 | 6.64 | 0.38 | 351.17/187.46 | 1.90 | Bullish |
| Baxter International | 24.42 | 3.56 | 15.93 | 11.96 | 2.61 | 1.99 | 40.42/26.26 | 2.29 | Bullish |
Market news
- Dow notches record high as Wall Street cheers Powell's speechAugust 23, 2025 10:31 AM
- Dow ends higher after UnitedHealth gains, other indexes slip on rate cut uncertaintyAugust 16, 2025 11:08 AM
- Stocks slump on latest tariffs, soft jobs dataAugust 2, 2025 11:55 AM
- S&P, Nasdaq end on subdued note after brief dip on latest Trump tariff rumblingJuly 19, 2025 9:45 AM
About the company
West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.